

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein localization to endosome (GO:0036010) | 3.88032157 |
| 2 | hypotonic response (GO:0006971) | 3.49429142 |
| 3 | barbed-end actin filament capping (GO:0051016) | 3.44167879 |
| 4 | COPI coating of Golgi vesicle (GO:0048205) | 3.39371365 |
| 5 | Golgi transport vesicle coating (GO:0048200) | 3.39371365 |
| 6 | embryonic process involved in female pregnancy (GO:0060136) | 3.37627429 |
| 7 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 3.33868777 |
| 8 | negative regulation of fatty acid transport (GO:2000192) | 3.33124342 |
| 9 | skin morphogenesis (GO:0043589) | 3.26528364 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.09238585 |
| 11 | cortical actin cytoskeleton organization (GO:0030866) | 3.06349058 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.04789407 |
| 13 | response to laminar fluid shear stress (GO:0034616) | 2.97448808 |
| 14 | regulation of early endosome to late endosome transport (GO:2000641) | 2.96357422 |
| 15 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.95152943 |
| 16 | stress fiber assembly (GO:0043149) | 2.93206439 |
| 17 | pinocytosis (GO:0006907) | 2.90013639 |
| 18 | mannose metabolic process (GO:0006013) | 2.86150612 |
| 19 | histone H3-K36 demethylation (GO:0070544) | 2.84679040 |
| 20 | regulation of ARF protein signal transduction (GO:0032012) | 2.84044148 |
| 21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.81311308 |
| 22 | cerebellar granule cell differentiation (GO:0021707) | 2.75913896 |
| 23 | COPII vesicle coating (GO:0048208) | 2.73912237 |
| 24 | regulation of extracellular matrix disassembly (GO:0010715) | 2.73370074 |
| 25 | sphingomyelin metabolic process (GO:0006684) | 2.71948175 |
| 26 | cortical cytoskeleton organization (GO:0030865) | 2.71314542 |
| 27 | fructose metabolic process (GO:0006000) | 2.69995451 |
| 28 | negative regulation of cell killing (GO:0031342) | 2.69910412 |
| 29 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.69910412 |
| 30 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.68558942 |
| 31 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.68394489 |
| 32 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.67543555 |
| 33 | cell volume homeostasis (GO:0006884) | 2.63385362 |
| 34 | regulation of cholesterol homeostasis (GO:2000188) | 2.61828991 |
| 35 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.58962998 |
| 36 | neutrophil activation involved in immune response (GO:0002283) | 2.56220947 |
| 37 | positive regulation of receptor recycling (GO:0001921) | 2.55574467 |
| 38 | glycosphingolipid catabolic process (GO:0046479) | 2.52923575 |
| 39 | vesicle coating (GO:0006901) | 2.50194736 |
| 40 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.47800105 |
| 41 | response to muramyl dipeptide (GO:0032495) | 2.45154551 |
| 42 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.42240025 |
| 43 | cell adhesion mediated by integrin (GO:0033627) | 2.41764095 |
| 44 | regulation of leukocyte degranulation (GO:0043300) | 2.39587077 |
| 45 | receptor recycling (GO:0001881) | 2.39418816 |
| 46 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.38837962 |
| 47 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.36092342 |
| 48 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.36031077 |
| 49 | regulation of macrophage cytokine production (GO:0010935) | 2.35391645 |
| 50 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.34217106 |
| 51 | positive regulation of extracellular matrix organization (GO:1903055) | 2.33677496 |
| 52 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.32843366 |
| 53 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.32730594 |
| 54 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.32521081 |
| 55 | macroautophagy (GO:0016236) | 2.32272148 |
| 56 | detection of other organism (GO:0098543) | 2.32090982 |
| 57 | cellular response to fluid shear stress (GO:0071498) | 2.30055438 |
| 58 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.27668355 |
| 59 | response to peptidoglycan (GO:0032494) | 2.27351653 |
| 60 | cell-substrate junction assembly (GO:0007044) | 2.26291165 |
| 61 | response to fluid shear stress (GO:0034405) | 2.25666157 |
| 62 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.24971529 |
| 63 | response to thyroid hormone (GO:0097066) | 2.24577174 |
| 64 | apoptotic cell clearance (GO:0043277) | 2.23884517 |
| 65 | hyaluronan catabolic process (GO:0030214) | 2.23656681 |
| 66 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.21652322 |
| 67 | glycolipid catabolic process (GO:0019377) | 2.21153710 |
| 68 | regulation of ARF GTPase activity (GO:0032312) | 2.20834127 |
| 69 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.20349618 |
| 70 | adherens junction assembly (GO:0034333) | 2.18513590 |
| 71 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.17412599 |
| 72 | focal adhesion assembly (GO:0048041) | 2.16895824 |
| 73 | cell-substrate adherens junction assembly (GO:0007045) | 2.16895824 |
| 74 | membrane raft organization (GO:0031579) | 2.16055230 |
| 75 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.15967379 |
| 76 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.15662260 |
| 77 | peptide catabolic process (GO:0043171) | 2.14837315 |
| 78 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.14347645 |
| 79 | mammary gland epithelial cell proliferation (GO:0033598) | 2.13897026 |
| 80 | regulation of lipid kinase activity (GO:0043550) | 2.13779303 |
| 81 | detection of molecule of bacterial origin (GO:0032490) | 2.13061800 |
| 82 | modulation by symbiont of host immune response (GO:0052553) | 2.12512412 |
| 83 | positive regulation by symbiont of host defense response (GO:0052509) | 2.12512412 |
| 84 | modulation by symbiont of host defense response (GO:0052031) | 2.12512412 |
| 85 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.12512412 |
| 86 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.12512412 |
| 87 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.12512412 |
| 88 | positive regulation of macrophage cytokine production (GO:0060907) | 2.12068026 |
| 89 | phospholipid dephosphorylation (GO:0046839) | 2.11424315 |
| 90 | membrane protein ectodomain proteolysis (GO:0006509) | 2.10371476 |
| 91 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.09599076 |
| 92 | protein localization to cell surface (GO:0034394) | 2.09562766 |
| 93 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.08742433 |
| 94 | filopodium assembly (GO:0046847) | 2.08698904 |
| 95 | oligosaccharide catabolic process (GO:0009313) | 2.07872461 |
| 96 | regulation of RNA export from nucleus (GO:0046831) | 2.07202899 |
| 97 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.07133927 |
| 98 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.06985037 |
| 99 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.05121530 |
| 100 | detection of bacterium (GO:0016045) | 2.04984759 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.03873181 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.52402056 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.09879298 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.69064682 |
| 5 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.66623206 |
| 6 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.57522342 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.54831529 |
| 8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.37740561 |
| 9 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.34745382 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30859427 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.20187873 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.17143029 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.14054829 |
| 14 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.07941853 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.93606888 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.91736209 |
| 17 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.91262671 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.90463768 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.89364311 |
| 20 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.87916075 |
| 21 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.84765698 |
| 22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.83095115 |
| 23 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.82083854 |
| 24 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.80175304 |
| 25 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.79832603 |
| 26 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.73705408 |
| 27 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.71827226 |
| 28 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.69320384 |
| 29 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.68603017 |
| 30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.67187153 |
| 31 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.66375545 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.60903738 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.58601389 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.57941024 |
| 35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.56940877 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.54385929 |
| 37 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.54171216 |
| 38 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.54156980 |
| 39 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.53097293 |
| 40 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.51742431 |
| 41 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51736843 |
| 42 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.51606970 |
| 43 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.50755533 |
| 44 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.50755533 |
| 45 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.50605752 |
| 46 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.49940099 |
| 47 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.49535909 |
| 48 | GATA1_19941826_ChIP-Seq_K562_Human | 1.49101433 |
| 49 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.47066149 |
| 50 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.47023706 |
| 51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.43139674 |
| 52 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.39439078 |
| 53 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.37403002 |
| 54 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.36640637 |
| 55 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.36078112 |
| 56 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.35506356 |
| 57 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.35506356 |
| 58 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34821297 |
| 59 | MAF_26560356_Chip-Seq_TH1_Human | 1.34684601 |
| 60 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.33756456 |
| 61 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.32165876 |
| 62 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.32078186 |
| 63 | MYC_22102868_ChIP-Seq_BL_Human | 1.31936505 |
| 64 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.30745818 |
| 65 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.29555672 |
| 66 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.27583709 |
| 67 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26061067 |
| 68 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.25631859 |
| 69 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.22437120 |
| 70 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.22197720 |
| 71 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.19740707 |
| 72 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.19688364 |
| 73 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18918396 |
| 74 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18562518 |
| 75 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.18055775 |
| 76 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.17864762 |
| 77 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.17259781 |
| 78 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.14594977 |
| 79 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.14004566 |
| 80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13999997 |
| 81 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13984104 |
| 82 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.13356299 |
| 83 | GATA2_19941826_ChIP-Seq_K562_Human | 1.13284589 |
| 84 | KDM2B_26808549_Chip-Seq_K562_Human | 1.13138518 |
| 85 | MYB_26560356_Chip-Seq_TH1_Human | 1.12661131 |
| 86 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11197852 |
| 87 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.11036802 |
| 88 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.11003802 |
| 89 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.10415668 |
| 90 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.08133690 |
| 91 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04467035 |
| 92 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04342809 |
| 93 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.03892816 |
| 94 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.03211975 |
| 95 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.01937558 |
| 96 | MYB_26560356_Chip-Seq_TH2_Human | 1.01719696 |
| 97 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01008157 |
| 98 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.00603899 |
| 99 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00362786 |
| 100 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.98101760 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 3.54186975 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.18916935 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 2.99380900 |
| 4 | MP0003172_abnormal_lysosome_physiology | 2.95216118 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 2.85322867 |
| 6 | MP0003300_gastrointestinal_ulcer | 2.55960079 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 2.54658887 |
| 8 | MP0003303_peritoneal_inflammation | 2.41743400 |
| 9 | MP0003566_abnormal_cell_adhesion | 2.37300276 |
| 10 | MP0002877_abnormal_melanocyte_morpholog | 2.35324301 |
| 11 | MP0009840_abnormal_foam_cell | 2.33602401 |
| 12 | MP0005409_darkened_coat_color | 2.22593413 |
| 13 | MP0006054_spinal_hemorrhage | 2.21656207 |
| 14 | MP0003091_abnormal_cell_migration | 2.11852458 |
| 15 | MP0008260_abnormal_autophagy | 2.07089888 |
| 16 | MP0010352_gastrointestinal_tract_polyps | 2.05104103 |
| 17 | MP0003436_decreased_susceptibility_to | 2.02539008 |
| 18 | MP0003828_pulmonary_edema | 2.00165214 |
| 19 | MP0005451_abnormal_body_composition | 1.96220189 |
| 20 | MP0005275_abnormal_skin_tensile | 1.95064591 |
| 21 | MP0003656_abnormal_erythrocyte_physiolo | 1.78441233 |
| 22 | MP0003183_abnormal_peptide_metabolism | 1.73994629 |
| 23 | MP0001958_emphysema | 1.68441850 |
| 24 | MP0003724_increased_susceptibility_to | 1.65192369 |
| 25 | MP0001835_abnormal_antigen_presentation | 1.63504261 |
| 26 | MP0003279_aneurysm | 1.62012994 |
| 27 | MP0010386_abnormal_urinary_bladder | 1.59779807 |
| 28 | MP0000465_gastrointestinal_hemorrhage | 1.54902001 |
| 29 | MP0001849_ear_inflammation | 1.48368512 |
| 30 | MP0000604_amyloidosis | 1.47365384 |
| 31 | MP0002060_abnormal_skin_morphology | 1.44925193 |
| 32 | MP0004272_abnormal_basement_membrane | 1.43787196 |
| 33 | MP0004947_skin_inflammation | 1.41888618 |
| 34 | MP0005076_abnormal_cell_differentiation | 1.41357774 |
| 35 | MP0001542_abnormal_bone_strength | 1.37347106 |
| 36 | MP0005623_abnormal_meninges_morphology | 1.36978964 |
| 37 | MP0002419_abnormal_innate_immunity | 1.34471956 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.30737087 |
| 39 | MP0002998_abnormal_bone_remodeling | 1.30283818 |
| 40 | MP0003329_amyloid_beta_deposits | 1.27473886 |
| 41 | MP0003453_abnormal_keratinocyte_physiol | 1.24604162 |
| 42 | MP0006082_CNS_inflammation | 1.21447870 |
| 43 | MP0000858_altered_metastatic_potential | 1.20578641 |
| 44 | MP0002009_preneoplasia | 1.20247820 |
| 45 | MP0003950_abnormal_plasma_membrane | 1.18497558 |
| 46 | MP0005023_abnormal_wound_healing | 1.18360108 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.17706002 |
| 48 | MP0005621_abnormal_cell_physiology | 1.17181625 |
| 49 | MP0002896_abnormal_bone_mineralization | 1.16045558 |
| 50 | MP0003763_abnormal_thymus_physiology | 1.13361238 |
| 51 | MP0003448_altered_tumor_morphology | 1.11345145 |
| 52 | MP0001915_intracranial_hemorrhage | 1.10572781 |
| 53 | MP0000767_abnormal_smooth_muscle | 1.10469247 |
| 54 | MP0005257_abnormal_intraocular_pressure | 1.09217090 |
| 55 | MP0008004_abnormal_stomach_pH | 1.08921457 |
| 56 | MP0003868_abnormal_feces_composition | 1.07955075 |
| 57 | MP0005025_abnormal_response_to | 1.07356943 |
| 58 | MP0010155_abnormal_intestine_physiology | 1.06477315 |
| 59 | MP0005000_abnormal_immune_tolerance | 1.06281628 |
| 60 | MP0005165_increased_susceptibility_to | 1.06162621 |
| 61 | MP0004510_myositis | 1.05275452 |
| 62 | MP0002166_altered_tumor_susceptibility | 1.04083671 |
| 63 | MP0010368_abnormal_lymphatic_system | 1.03708791 |
| 64 | MP0008874_decreased_physiological_sensi | 1.02786729 |
| 65 | MP0004036_abnormal_muscle_relaxation | 1.01333183 |
| 66 | MP0000685_abnormal_immune_system | 1.01208502 |
| 67 | MP0005387_immune_system_phenotype | 1.01030358 |
| 68 | MP0001790_abnormal_immune_system | 1.01030358 |
| 69 | MP0001851_eye_inflammation | 0.98648719 |
| 70 | MP0000015_abnormal_ear_pigmentation | 0.97918511 |
| 71 | MP0005503_abnormal_tendon_morphology | 0.97452163 |
| 72 | MP0005166_decreased_susceptibility_to | 0.97212367 |
| 73 | MP0005164_abnormal_response_to | 0.96868989 |
| 74 | MP0004264_abnormal_extraembryonic_tissu | 0.94754558 |
| 75 | MP0003690_abnormal_glial_cell | 0.94442194 |
| 76 | MP0003866_abnormal_defecation | 0.90830247 |
| 77 | MP0004484_altered_response_of | 0.90629852 |
| 78 | MP0002796_impaired_skin_barrier | 0.90123491 |
| 79 | MP0002452_abnormal_antigen_presenting | 0.88612604 |
| 80 | MP0000343_altered_response_to | 0.88460852 |
| 81 | MP0003795_abnormal_bone_structure | 0.87179418 |
| 82 | MP0000920_abnormal_myelination | 0.86763930 |
| 83 | MP0000751_myopathy | 0.85836273 |
| 84 | MP0002396_abnormal_hematopoietic_system | 0.85617678 |
| 85 | MP0001243_abnormal_dermal_layer | 0.85151394 |
| 86 | MP0003221_abnormal_cardiomyocyte_apopto | 0.84097232 |
| 87 | MP0001800_abnormal_humoral_immune | 0.83035333 |
| 88 | MP0009785_altered_susceptibility_to | 0.82577921 |
| 89 | MP0004084_abnormal_cardiac_muscle | 0.81949084 |
| 90 | MP0005384_cellular_phenotype | 0.80337901 |
| 91 | MP0005595_abnormal_vascular_smooth | 0.79680084 |
| 92 | MP0002723_abnormal_immune_serum | 0.78212492 |
| 93 | MP0002405_respiratory_system_inflammati | 0.77595446 |
| 94 | MP0001819_abnormal_immune_cell | 0.77013426 |
| 95 | MP0002420_abnormal_adaptive_immunity | 0.76995855 |
| 96 | MP0000013_abnormal_adipose_tissue | 0.76613423 |
| 97 | MP0004233_abnormal_muscle_weight | 0.74822783 |
| 98 | MP0001845_abnormal_inflammatory_respons | 0.72499917 |
| 99 | MP0003879_abnormal_hair_cell | 0.72426487 |
| 100 | MP0004808_abnormal_hematopoietic_stem | 0.72208812 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Scanning speech (HP:0002168) | 3.87198435 |
| 2 | Dysmetric saccades (HP:0000641) | 3.61709798 |
| 3 | Protrusio acetabuli (HP:0003179) | 3.61213204 |
| 4 | Vertebral compression fractures (HP:0002953) | 3.27168777 |
| 5 | Premature rupture of membranes (HP:0001788) | 3.26061166 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.05425855 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.05425855 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 3.05425855 |
| 9 | Aortic aneurysm (HP:0004942) | 3.03024055 |
| 10 | Vascular tortuosity (HP:0004948) | 2.87692391 |
| 11 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.85382722 |
| 12 | Osteolytic defects of the hand bones (HP:0009699) | 2.85382722 |
| 13 | Cervical subluxation (HP:0003308) | 2.82877860 |
| 14 | Dysostosis multiplex (HP:0000943) | 2.72793945 |
| 15 | Arterial tortuosity (HP:0005116) | 2.71409884 |
| 16 | Distal lower limb amyotrophy (HP:0008944) | 2.61458449 |
| 17 | Eczematoid dermatitis (HP:0000976) | 2.60738225 |
| 18 | Spondylolisthesis (HP:0003302) | 2.55277089 |
| 19 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.46230662 |
| 20 | Mucopolysacchariduria (HP:0008155) | 2.45918912 |
| 21 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.45918912 |
| 22 | Dilatation of the ascending aorta (HP:0005111) | 2.40460552 |
| 23 | Tetraparesis (HP:0002273) | 2.35841144 |
| 24 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.35548702 |
| 25 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.35548702 |
| 26 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.35548702 |
| 27 | Cerebral aneurysm (HP:0004944) | 2.30997839 |
| 28 | Wormian bones (HP:0002645) | 2.30659253 |
| 29 | Aortic dissection (HP:0002647) | 2.29927958 |
| 30 | Aneurysm (HP:0002617) | 2.29719787 |
| 31 | Absent frontal sinuses (HP:0002688) | 2.29230621 |
| 32 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.26501769 |
| 33 | Increased connective tissue (HP:0009025) | 2.21160611 |
| 34 | Action tremor (HP:0002345) | 2.20624667 |
| 35 | Myocardial infarction (HP:0001658) | 2.20044996 |
| 36 | Neurofibrillary tangles (HP:0002185) | 2.19015569 |
| 37 | Postural tremor (HP:0002174) | 2.18623070 |
| 38 | Distal upper limb amyotrophy (HP:0007149) | 2.15449157 |
| 39 | Upper limb amyotrophy (HP:0009129) | 2.15449157 |
| 40 | Termporal pattern (HP:0011008) | 2.11531217 |
| 41 | Insidious onset (HP:0003587) | 2.11531217 |
| 42 | Abnormality of macrophages (HP:0004311) | 2.09611464 |
| 43 | Increased variability in muscle fiber diameter (HP:0003557) | 2.07384094 |
| 44 | Atrophic scars (HP:0001075) | 2.05621377 |
| 45 | Flat acetabular roof (HP:0003180) | 2.02938923 |
| 46 | Loss of speech (HP:0002371) | 2.00374105 |
| 47 | Abnormality of saccadic eye movements (HP:0000570) | 1.99560153 |
| 48 | Spinal rigidity (HP:0003306) | 1.99146767 |
| 49 | Nuclear cataract (HP:0100018) | 1.97966504 |
| 50 | Dysdiadochokinesis (HP:0002075) | 1.96217314 |
| 51 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.95745158 |
| 52 | Cerebral inclusion bodies (HP:0100314) | 1.94948186 |
| 53 | Truncal ataxia (HP:0002078) | 1.92969289 |
| 54 | Ankle contracture (HP:0006466) | 1.92856148 |
| 55 | Recurrent bacterial skin infections (HP:0005406) | 1.92465280 |
| 56 | Gingivitis (HP:0000230) | 1.91702325 |
| 57 | Distal lower limb muscle weakness (HP:0009053) | 1.91506026 |
| 58 | Resting tremor (HP:0002322) | 1.91174080 |
| 59 | Hand muscle atrophy (HP:0009130) | 1.91057522 |
| 60 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.90256597 |
| 61 | Spinal cord lesions (HP:0100561) | 1.88424822 |
| 62 | Syringomyelia (HP:0003396) | 1.88424822 |
| 63 | Amyloidosis (HP:0011034) | 1.86904360 |
| 64 | Subacute progressive viral hepatitis (HP:0006572) | 1.86525461 |
| 65 | Mitral stenosis (HP:0001718) | 1.85712736 |
| 66 | Fragile skin (HP:0001030) | 1.84879446 |
| 67 | Recurrent abscess formation (HP:0002722) | 1.84518306 |
| 68 | Autoamputation (HP:0001218) | 1.83383045 |
| 69 | Broad face (HP:0000283) | 1.83175828 |
| 70 | Asymmetric septal hypertrophy (HP:0001670) | 1.82056166 |
| 71 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.81403387 |
| 72 | Short nail (HP:0001799) | 1.81371457 |
| 73 | Abnormality of the frontal sinuses (HP:0002687) | 1.80725081 |
| 74 | Thin bony cortex (HP:0002753) | 1.80723505 |
| 75 | Periodontitis (HP:0000704) | 1.78450988 |
| 76 | Skin nodule (HP:0200036) | 1.77063751 |
| 77 | Mitral valve prolapse (HP:0001634) | 1.76898979 |
| 78 | Abnormality of the thoracic spine (HP:0100711) | 1.76201643 |
| 79 | Colitis (HP:0002583) | 1.75231659 |
| 80 | Thoracic kyphosis (HP:0002942) | 1.75166926 |
| 81 | Atonic seizures (HP:0010819) | 1.74721496 |
| 82 | Lower limb amyotrophy (HP:0007210) | 1.74422826 |
| 83 | Cellulitis (HP:0100658) | 1.73949471 |
| 84 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.73330157 |
| 85 | Supranuclear gaze palsy (HP:0000605) | 1.72190157 |
| 86 | Obstructive sleep apnea (HP:0002870) | 1.71343455 |
| 87 | Dysmetria (HP:0001310) | 1.71330157 |
| 88 | Abnormality of dentin (HP:0010299) | 1.71280320 |
| 89 | Peritonitis (HP:0002586) | 1.70929237 |
| 90 | Emphysema (HP:0002097) | 1.70726380 |
| 91 | Systemic lupus erythematosus (HP:0002725) | 1.69991076 |
| 92 | Horizontal nystagmus (HP:0000666) | 1.69298279 |
| 93 | Genu recurvatum (HP:0002816) | 1.66471089 |
| 94 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.66439432 |
| 95 | Abnormality of the nasal mucosa (HP:0000433) | 1.64245179 |
| 96 | Interstitial pulmonary disease (HP:0006530) | 1.64011040 |
| 97 | Joint laxity (HP:0001388) | 1.62154947 |
| 98 | Upper motor neuron abnormality (HP:0002127) | 1.61654758 |
| 99 | Apathy (HP:0000741) | 1.60939296 |
| 100 | Vertebral arch anomaly (HP:0008438) | 1.60758989 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.19974475 |
| 2 | CDK12 | 2.64216172 |
| 3 | ERN1 | 2.39896419 |
| 4 | RIPK1 | 2.35452459 |
| 5 | TRIB3 | 2.27909743 |
| 6 | MAP3K14 | 2.06811407 |
| 7 | SCYL2 | 2.06405607 |
| 8 | KSR2 | 1.96145478 |
| 9 | MST1R | 1.93629568 |
| 10 | MAP3K13 | 1.92419161 |
| 11 | MYLK | 1.88676502 |
| 12 | MAP3K12 | 1.88486431 |
| 13 | PDGFRA | 1.87795025 |
| 14 | TYK2 | 1.85982209 |
| 15 | JAK1 | 1.70664027 |
| 16 | RIPK4 | 1.68178764 |
| 17 | FGFR4 | 1.57259853 |
| 18 | TTN | 1.55196531 |
| 19 | PAK4 | 1.53844064 |
| 20 | IRAK3 | 1.51877188 |
| 21 | MAP2K3 | 1.46198428 |
| 22 | WNK1 | 1.43691448 |
| 23 | MAP3K1 | 1.42930034 |
| 24 | ICK | 1.41609278 |
| 25 | BLK | 1.40517040 |
| 26 | TBK1 | 1.39430237 |
| 27 | ZAP70 | 1.37493426 |
| 28 | CDK6 | 1.32522897 |
| 29 | TESK1 | 1.27692579 |
| 30 | FGFR3 | 1.26751061 |
| 31 | EPHB1 | 1.25412555 |
| 32 | MAP3K3 | 1.24375595 |
| 33 | PTK6 | 1.24023535 |
| 34 | CSK | 1.22750233 |
| 35 | CDC42BPA | 1.21000847 |
| 36 | MAP3K2 | 1.20164012 |
| 37 | SIK1 | 1.13876831 |
| 38 | MOS | 1.10896722 |
| 39 | NEK9 | 1.08677825 |
| 40 | SMG1 | 1.05209479 |
| 41 | ARAF | 1.05071393 |
| 42 | TGFBR2 | 1.04419794 |
| 43 | JAK3 | 1.01236841 |
| 44 | EEF2K | 1.00629101 |
| 45 | DDR2 | 0.99748972 |
| 46 | TRPM7 | 0.99643615 |
| 47 | GRK5 | 0.97243288 |
| 48 | CLK1 | 0.92210550 |
| 49 | PDGFRB | 0.92144036 |
| 50 | MARK2 | 0.89509945 |
| 51 | BRD4 | 0.89284300 |
| 52 | MET | 0.88970578 |
| 53 | MAP3K9 | 0.85025945 |
| 54 | * MTOR | 0.81171843 |
| 55 | EPHA2 | 0.80621870 |
| 56 | PAK2 | 0.80463690 |
| 57 | PTK2 | 0.78925812 |
| 58 | GRK6 | 0.77450220 |
| 59 | PDK1 | 0.75858299 |
| 60 | FES | 0.75270927 |
| 61 | ROCK2 | 0.73935807 |
| 62 | BMPR2 | 0.72274602 |
| 63 | IKBKE | 0.72257213 |
| 64 | STK38 | 0.71353680 |
| 65 | RET | 0.70195864 |
| 66 | TAOK2 | 0.69881299 |
| 67 | PRKG2 | 0.69632384 |
| 68 | RAF1 | 0.69343416 |
| 69 | CAMK1G | 0.67581936 |
| 70 | PDPK1 | 0.67485167 |
| 71 | PRKD2 | 0.67226431 |
| 72 | KSR1 | 0.65291434 |
| 73 | RPS6KA2 | 0.64238603 |
| 74 | SGK3 | 0.64176369 |
| 75 | SIK3 | 0.64081069 |
| 76 | LATS2 | 0.62712456 |
| 77 | MAPK7 | 0.62168208 |
| 78 | JAK2 | 0.61632307 |
| 79 | FGR | 0.60991134 |
| 80 | CSF1R | 0.60635744 |
| 81 | IRAK4 | 0.59929555 |
| 82 | MAP2K2 | 0.59442983 |
| 83 | NEK6 | 0.58452831 |
| 84 | STK10 | 0.56394657 |
| 85 | BTK | 0.54819428 |
| 86 | HCK | 0.52908070 |
| 87 | NTRK1 | 0.52423072 |
| 88 | MAP3K6 | 0.51472091 |
| 89 | FYN | 0.50461228 |
| 90 | PAK6 | 0.50151287 |
| 91 | CDK9 | 0.49164825 |
| 92 | IRAK2 | 0.48448434 |
| 93 | MAP3K8 | 0.47901979 |
| 94 | MARK3 | 0.47031901 |
| 95 | YES1 | 0.45995954 |
| 96 | LATS1 | 0.44834837 |
| 97 | MAP2K1 | 0.43192768 |
| 98 | TESK2 | 0.40547273 |
| 99 | HIPK2 | 0.38762654 |
| 100 | RPS6KC1 | 0.38548491 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.84177557 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.03040785 |
| 3 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.96222833 |
| 4 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.88787753 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.73576134 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.65826525 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 1.56092782 |
| 8 | Long-term depression_Homo sapiens_hsa04730 | 1.56083333 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.55768952 |
| 10 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.54998918 |
| 11 | Amoebiasis_Homo sapiens_hsa05146 | 1.46330037 |
| 12 | Lysosome_Homo sapiens_hsa04142 | 1.45733689 |
| 13 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.45102003 |
| 14 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.42013639 |
| 15 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.35413295 |
| 16 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.27909792 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.27668171 |
| 18 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.22689035 |
| 19 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.20441459 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.18970846 |
| 21 | Focal adhesion_Homo sapiens_hsa04510 | 1.17788285 |
| 22 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.17315377 |
| 23 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.15903120 |
| 24 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.15363575 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.15262901 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.14553465 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.14257178 |
| 28 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.10861730 |
| 29 | Endometrial cancer_Homo sapiens_hsa05213 | 1.10682394 |
| 30 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.10460709 |
| 31 | Hepatitis B_Homo sapiens_hsa05161 | 1.09312745 |
| 32 | Hepatitis C_Homo sapiens_hsa05160 | 1.06612535 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06367095 |
| 34 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.04635255 |
| 35 | Glioma_Homo sapiens_hsa05214 | 1.03974590 |
| 36 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.03898979 |
| 37 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.03870195 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.03631452 |
| 39 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.03580161 |
| 40 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.00311764 |
| 41 | Gap junction_Homo sapiens_hsa04540 | 1.00002581 |
| 42 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.99537258 |
| 43 | Renin secretion_Homo sapiens_hsa04924 | 0.99262436 |
| 44 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.98946089 |
| 45 | Platelet activation_Homo sapiens_hsa04611 | 0.98684512 |
| 46 | Thyroid cancer_Homo sapiens_hsa05216 | 0.96614646 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 0.96176391 |
| 48 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95877740 |
| 49 | Adherens junction_Homo sapiens_hsa04520 | 0.95210090 |
| 50 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.95155902 |
| 51 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.93072955 |
| 52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93007028 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.92973458 |
| 54 | Influenza A_Homo sapiens_hsa05164 | 0.91561025 |
| 55 | * Endocytosis_Homo sapiens_hsa04144 | 0.88863929 |
| 56 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.85278695 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 0.83935901 |
| 58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.83724762 |
| 59 | Prostate cancer_Homo sapiens_hsa05215 | 0.83200534 |
| 60 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.83064249 |
| 61 | Malaria_Homo sapiens_hsa05144 | 0.81865166 |
| 62 | Prion diseases_Homo sapiens_hsa05020 | 0.81109827 |
| 63 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.79589556 |
| 64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.79048556 |
| 65 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.76945520 |
| 66 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.76693397 |
| 67 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76681115 |
| 68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75872147 |
| 69 | Shigellosis_Homo sapiens_hsa05131 | 0.74610725 |
| 70 | Bladder cancer_Homo sapiens_hsa05219 | 0.73610078 |
| 71 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.73474526 |
| 72 | Pertussis_Homo sapiens_hsa05133 | 0.72908526 |
| 73 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.72286354 |
| 74 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.72276711 |
| 75 | Measles_Homo sapiens_hsa05162 | 0.72159176 |
| 76 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.70269858 |
| 77 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.69837839 |
| 78 | Salivary secretion_Homo sapiens_hsa04970 | 0.66756144 |
| 79 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.66727699 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65955244 |
| 81 | Salmonella infection_Homo sapiens_hsa05132 | 0.65643887 |
| 82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.65114912 |
| 83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.65015546 |
| 84 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64738859 |
| 85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64347987 |
| 86 | Viral myocarditis_Homo sapiens_hsa05416 | 0.63284062 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.63071053 |
| 88 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.62665158 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61757690 |
| 90 | Colorectal cancer_Homo sapiens_hsa05210 | 0.61236234 |
| 91 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60795572 |
| 92 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60152403 |
| 93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58231334 |
| 94 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.57879152 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57724435 |
| 96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57433933 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54063742 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53858691 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.50604426 |
| 100 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.50217802 |

